Liposomal formulation of idarubicin

Acta Poloniae Pharmaceutica - Drug Research

Volumn 60, Issue 2, 2003, Pages 138-140

  Ślifirski, Piotr ^a   Szelejewski, Wiesław ^a   Grynkiewicz, Grzegorz ^a   Gubernator, Jerzy ^b   Kozubek, Arkadiusz ^b  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN; LIPOSOME;

ARTICLE; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; ENCAPSULATION; FREEZE DRYING; GASTROINTESTINAL DISEASE; GRANULOCYTOPENIA; HUMAN; THAWING; TISSUE INJURY;

CHEMISTRY, PHARMACEUTICAL; IDARUBICIN; LIPOSOMES;

EID: 0037958744     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Perez-Soler R., Yiyu Zou, Yi-he Ling, Priebe W.: J. Liposome Res. 4, 555 (1994).
2. Wiela-Hojeńska A., Drogosz H.: Farm. Pol. 52, 110 (1996).
3. Podlewski J. K., Chwalibogowska-Podlewska A.: in Leki współczesnej terapii. Wydawnictwa Fundacji Büchnera, Warsaw 1999.
4. Oszczapowicz I., Wasowska M.: Farm. Pol. 55, 80 (1999).
5. Rouser G., Siakotos A. N., Fleischer S.: Lipids 1, 85 (1966).
6. Lasic D. D. Liposomes: From Physics To Aplications, Elsevier Science B.V., Amsterdam 1993.
7. Langner M., Kral T.E.: Pol. J. Pharmacol. 51, 211 (1999).
8. Lian T., Ho R.J.Y.: J. Pharm. Sci. 90, 667 (2001).